Geron (GERN)
(Delayed Data from NSDQ)
$4.71 USD
-0.03 (-0.63%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $4.71 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Geron Corporation [GERN]
Reports for Purchase
Showing records 1 - 20 ( 247 total )
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Q2 Financials; Imetelstat Hits the Market, All Indicators Positive
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
CCO Departs; Remain Bullish on Commercial Outlook
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Ready to Rumble; Capitalizing on Robust Opportunity for Rytelo
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
RYTELO (imetelstat) Approved; Label Looks Best-Case
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
We?re Not Surprised; AdCom Votes in Favor of Imetelstat
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Briefing Docs In-Line with Expectations; Remain Confident in Imetelstat
Provider: Wedbush Securities Inc.
Analyst: DRISCOLL R
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
Company: Geron Corporation
Industry: Medical - Biomedical and Genetics
ASH 2023 Day 3 Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D